Literature DB >> 21763894

Analysis of the antimicrobial susceptibility of anaerobic bacteria isolated from endodontic infections in Brazil during a period of nine years.

Brenda P F A Gomes1, Rogério C Jacinto, Francisco Montagner, Ezilmara L R Sousa, Caio C R Ferraz.   

Abstract

INTRODUCTION: The purpose of this study was to analyze the susceptibility of some anaerobic species isolated from a Brazilian population at different periods of time by determining a pattern of development of resistance to frequently prescribed antibiotics in endodontics.
METHODS: Root canal samples were collected from infected teeth at different periods of time (2000-2002, 2003-2005, and 2007-2008) and microbiologically identified with conventional culture techniques. The susceptibility of Prevotella intermedia/nigrescens, P. oralis, Fusobacterium nucleatum, and P. micra isolated strains was determined by the minimum inhibitory concentration (MIC) of amoxicillin, amoxicillin + clavulanate, benzylpenicillin, clindamycin, erythromycin, and metronidazole by using the E-test method.
RESULTS: Amoxicillin and amoxicillin + clavulanate were effective against the majority of species at the different periods of study. Overall, there were low statistical differences regarding the microbial susceptibility between the experimental periods. However, an increase in the anaerobic resistance to penicillin G and clindamycin was observed. Resistance to erythromycin was observed in all species, and there were statistically significant differences between 2000-2002 and 2003-2005 periods for F. nucleatum (P < .05) and between 2003-2005 and 2007-2008 periods for P. intermedia/nigrescens and P. oralis (P < .05).
CONCLUSIONS: The antimicrobial resistance of anaerobes isolated from primary endodontic infections showed an increase throughout a period of time regarding a specific Brazilian population.
Copyright © 2011 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763894     DOI: 10.1016/j.joen.2011.05.015

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  5 in total

1.  Molecular characterization and antibacterial activity of oral antibiotics and copper nanoparticles against endodontic pathogens commonly related to health care-associated infections.

Authors:  Fernanda Katherine Sacoto-Figueroa; Helia Magali Bello-Toledo; Gerardo Enrique González-Rocha; Luis Luengo Machuca; Celia A Lima; Manuel Meléndrez-Castro; Gabriela Alejandra Sánchez-Sanhueza
Journal:  Clin Oral Investig       Date:  2021-04-24       Impact factor: 3.573

2.  Microbiological profile and antimicrobial susceptibility pattern of infected root canals associated with periapical abscesses.

Authors:  E L R Sousa; B P F A Gomes; R C Jacinto; A A Zaia; C C R Ferraz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-06       Impact factor: 3.267

3.  Detection of Streptococcus mutans in symptomatic and asymptomatic infected root canals.

Authors:  Augusto Rodrigues Lima; Daniel Rodrigo Herrera; Priscila Amanda Francisco; Andrea Cardoso Pereira; Jose Lemos; Jacqueline Abranches; Brenda P F A Gomes
Journal:  Clin Oral Investig       Date:  2020-11-10       Impact factor: 3.573

Review 4.  Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeri in an immunocompetent adult: a case report and literature review.

Authors:  Min Ji Lee; Young Eun Ha; Hye Yon Park; Jun Hee Lee; Yoon Jung Lee; Ki Sun Sung; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Kyong Ran Peck
Journal:  BMC Infect Dis       Date:  2012-07-20       Impact factor: 3.090

Review 5.  Resistance profile to antimicrobial agents in the main circulating bacteria isolated from acute periodontal and endodontic infections in Latin America (MICROBE- DENT): A systematic review protocol.

Authors:  Flávia Casale Abe; Cristiane de Cássia Bergamaschi; Mabel Fernandes Figueiró; Luciane Cruz Lopes
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.